Search
Menu
Home
Sources
About
Contacts
LY-344545
LY-344,545
is a
research
drug
developed by the
pharmaceutical company
Eli Lilly
, which
acts
as an
antagonist
for the
metabotropic glutamate receptor
subtype
mGluR
5
. It is an
epimer
of another
metabotropic
glutamate receptor
antagonist, the mGluR
2/3
-selective
LY-341,495
.